Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.
暂无分享,去创建一个
[1] L. Vassilev,et al. Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma. , 2005, Blood.
[2] Steffen Hauptmann,et al. Significance of HDMX‐S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis , 2005, International journal of cancer.
[3] Marina Konopleva,et al. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. , 2005, Blood.
[4] A. Marchetti,et al. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. , 2005, Cancer research.
[5] T. Kuwana,et al. PUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53 , 2005, Science.
[6] H. Ovaa,et al. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. , 2005, Molecular cell.
[7] G. Stark,et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2 , 2005, Journal of Cell Science.
[8] Petra de Graaf,et al. Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] Hui Wang,et al. Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanisms. , 2005, Current cancer drug targets.
[10] M. Protopopova,et al. Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors , 2004, Nature Medicine.
[11] Zigang Dong,et al. Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.
[12] Kristian Helin,et al. Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity , 2004, Molecular and Cellular Biology.
[13] Patrick Dumont,et al. Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex , 2004, Nature Cell Biology.
[14] R. Iggo,et al. Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells* , 2004, Journal of Biological Chemistry.
[15] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[16] C. Cordon-Cardo,et al. MDM2 and prognosis. , 2004, Molecular cancer research : MCR.
[17] Guillermina Lozano,et al. MDM2, an introduction. , 2003, Molecular cancer research : MCR.
[18] S. Berberich,et al. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation. , 2003, Biochemistry.
[19] Petr Pancoska,et al. p53 has a direct apoptogenic role at the mitochondria. , 2003, Molecular cell.
[20] M. Murphy,et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.
[21] P. Chène. Inhibiting the p53–MDM2 interaction: an important target for cancer therapy , 2003, Nature Reviews Cancer.
[22] A. Haas,et al. MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination* , 2002, The Journal of Biological Chemistry.
[23] G. Hannon,et al. Transformation of normal human cells in the absence of telomerase activation. , 2002, Cancer cell.
[24] K. Helin,et al. Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development , 2002, Molecular and Cellular Biology.
[25] R. Ramirez-Solis,et al. mdmx is a negative regulator of p53 activity in vivo. , 2002, Cancer research.
[26] A. Jochemsen,et al. Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53* , 2002, The Journal of Biological Chemistry.
[27] Galina Selivanova,et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound , 2002, Nature Medicine.
[28] N. Little,et al. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms , 2001, EMBO reports.
[29] Valerie Reinke,et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.
[30] Yolande F M Ramos,et al. Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. , 2001, Cancer research.
[31] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[32] N. Little,et al. Hdmx stabilizes Mdm2 and p53. , 2000, The Journal of biological chemistry.
[33] M. Jackson,et al. MdmX Protects p53 from Mdm2-Mediated Degradation , 2000, Molecular and Cellular Biology.
[34] D. George,et al. Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein* , 1999, The Journal of Biological Chemistry.
[35] M. Jackson,et al. Constitutive mdmx expression during cell growth, differentiation, and DNA damage. , 1999, DNA and cell biology.
[36] K. Shirouzu,et al. MDM2 interacts with MDMX through their RING finger domains , 1999, FEBS letters.
[37] W. Mercer,et al. A Novel MDMX Transcript Expressed in a Variety of Transformed Cell Lines Encodes a Truncated Protein with Potent p53 Repressive Activity* , 1999, The Journal of Biological Chemistry.
[38] Yolande F M Ramos,et al. Comparative study of the p53-mdm2 and p53-MDMX interfaces , 1999, Oncogene.
[39] J. Turchi,et al. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. , 1997, Cancer research.
[40] D. Lane,et al. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding , 1997, Oncogene.
[41] A. Jochemsen,et al. MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.
[42] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[43] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[44] A. Levine,et al. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[46] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[47] J. Levine,et al. Surfing the p53 network , 2000, Nature.